| 000 | 00000nam 2200000zi 4500 |
| 001 | 9.944611 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20250213145445 |
|---|
| 006 | m o d f |
|---|
| 007 | cr mn||||||||| |
|---|
| 008 | 241029e20241115onca ob f000 0 eng d |
|---|
| 020 | |a9780660742380 |q(statement) |
|---|
| 020 | |a9780660742397 |q(summary) |
|---|
| 020 | |a9780660742403 |q(supplement) |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aHP40-373/2024E-PDF |
|---|
| 086 | 1 |aHP40-373/2024-1E-PDF |
|---|
| 086 | 1 |aHP40-373/2024-2E-PDF |
|---|
| 245 | 00|aRecommendations on the use of pneumococcal vaccines in adults, including PNEU-C-21. |
|---|
| 264 | 1|aOttawa, ON : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |cNovember 15, 2024. |
|---|
| 264 | 4|c©2024 |
|---|
| 300 | |a1 online resource (61 pages) : |bcolour illustrations + |esummary (5 pages) + supplement (22 pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Recommandations sur l'utilisation des vaccins contre le Issued also in French under title: Recommandations sur l'utilisation des vaccins contre le pneumocoque chez les adultes, y compris le PNEU-C-21. |
|---|
| 500 | |aOn cover: An advisory committee statement (ACS), National Advisory Committee on Immunization (NACI). |
|---|
| 500 | |a"Pub.: 240596"--Page 2. |
|---|
| 500 | |a"Pub.: 240598"--Page 2 (summary). |
|---|
| 500 | |a"Pub.: 240600"--Page 2 (supplement). |
|---|
| 504 | |aIncludes bibliographical references. |
|---|
| 650 | 0|aPneumococcal vaccine|xGovernment policy|zCanada. |
|---|
| 650 | 0|aStreptococcal infections|xVaccination|xGovernment policy|zCanada. |
|---|
| 710 | 2 |aPublic Health Agency of Canada, |eissuing body. |
|---|
| 710 | 1 |aCanada. |bNational Advisory Committee on Immunization, |eissuing body. |
|---|
| 775 | 08|tRecommandations sur l'utilisation des vaccins contre le pneumocoque chez les adultes, y compris le PNEU-C-21.|w(CaOODSP)9.944614 |
|---|
| 856 | 40|qPDF|s1.08 MB|uhttps://publications.gc.ca/collections/collection_2025/aspc-phac/HP40-373-2024-eng.pdf|z(statement) |
|---|
| 856 | 40|qPDF|s266 KB|uhttps://publications.gc.ca/collections/collection_2025/aspc-phac/HP40-373-2024-1-eng.pdf|z(summary) |
|---|
| 856 | 40|qPDF|s463 KB|uhttps://publications.gc.ca/collections/collection_2025/aspc-phac/HP40-373-2024-2-eng.pdf|z(supplement) |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/public-health/services/publications/vaccines-immunization/national-advisory-committee-immunization-statement-recommendations-use-pneumococcal-vaccines-adults-pneu-c-21.html|z(statement) |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/public-health/services/publications/vaccines-immunization/national-advisory-committee-immunization-summary-recommendations-use-pneumococcal-vaccines-adults-pneu-c-21.html|z(summary) |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/public-health/services/publications/vaccines-immunization/national-advisory-committee-immunization-supplement-recommendations-use-pneumococcal-vaccines-adults-pneu-c-21.html|z(supplement) |
|---|
| 986 | |a240596 |
|---|
| 986 | |a240598 |
|---|
| 986 | |a240600 |
|---|